Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 2115.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. SPANBERGER, as printed in the Congressional Record (Vol. 165, No. 60, April 8, 2019, Page H3129):
  Article I, Section 8, Clause 18
  Source: Congress.gov, Congressional Record April 8, 2019 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  31 characters

  Congress.gov bill record

  H.R. 2115, 116th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/116/hr/2115

  Record last updated by Congress.gov

  May 28, 2025

  PORKER copy retrieved

  September 20, 2026

  Stored copy, SHA-256 of the file

  a59fe7c687fdc8cd538b7dc260b52af6667b3bb2aaf6c0720a329a2c2a038b7e

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of May 28, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 2115, last updated May 28, 2025. PORKER’s copy was retrieved September 20, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.